A detailed history of Braun Bostich & Associates Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Braun Bostich & Associates Inc. holds 7,777 shares of JNJ stock, worth $1.21 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
7,777
Previous 7,294 6.62%
Holding current value
$1.21 Million
Previous $1.07 Million 18.2%
% of portfolio
0.9%
Previous 0.81%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$145.48 - $167.38 $70,266 - $80,844
483 Added 6.62%
7,777 $1.26 Million
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $90,959 - $99,401
630 Added 9.45%
7,294 $1.07 Million
Q1 2024

Apr 29, 2024

BUY
$155.22 - $162.74 $49,204 - $51,588
317 Added 4.99%
6,664 $1.05 Million
Q4 2023

Jan 29, 2024

BUY
$145.6 - $158.88 $707,761 - $772,315
4,861 Added 327.12%
6,347 $994,000
Q3 2023

Nov 01, 2023

SELL
$155.75 - $174.48 $515,376 - $577,354
-3,309 Reduced 69.01%
1,486 $231,000
Q2 2023

Jul 25, 2023

BUY
$154.35 - $166.11 $50,626 - $54,484
328 Added 7.34%
4,795 $793,000
Q1 2023

May 01, 2023

BUY
$151.05 - $180.26 $72,050 - $85,984
477 Added 11.95%
4,467 $692,000
Q4 2022

Feb 09, 2023

BUY
$160.2 - $179.79 $27,554 - $30,923
172 Added 4.5%
3,990 $704,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $12,906 - $14,361
80 Added 2.14%
3,818 $624,000
Q2 2022

Aug 16, 2022

BUY
$168.19 - $186.01 $19,005 - $21,019
113 Added 3.12%
3,738 $664,000
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $359,926 - $408,746
2,276 Added 168.72%
3,625 $642,000
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $290,653 - $322,490
-1,864 Reduced 58.01%
1,349 $226,000
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $11,163 - $11,974
-70 Reduced 2.13%
3,213 $529,000
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $5,357 - $5,966
-35 Reduced 1.05%
3,283 $540,000
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $495,926 - $569,243
-3,617 Reduced 52.16%
3,318 $522,000
Q3 2020

Oct 09, 2020

SELL
$140.38 - $153.83 $488,522 - $535,328
-3,480 Reduced 33.41%
6,935 $1.03 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $31,300 - $37,788
243 Added 2.39%
10,415 $1.47 Million
Q1 2020

May 11, 2020

SELL
$111.14 - $153.99 $41,899 - $58,054
-377 Reduced 3.57%
10,172 $1.31 Million
Q4 2019

Jan 29, 2020

SELL
$127.5 - $146.44 $14,280 - $16,401
-112 Reduced 1.05%
10,549 $1.54 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $49,129 - $55,008
387 Added 3.77%
10,661 $1.38 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $5,377 - $5,913
-41 Reduced 0.4%
10,274 $1.43 Million
Q1 2019

May 09, 2019

SELL
$125.72 - $139.79 $234,970 - $261,267
-1,869 Reduced 15.34%
10,315 $1.44 Million
Q4 2018

Feb 08, 2019

SELL
$122.84 - $147.84 $439,153 - $528,528
-3,575 Reduced 22.69%
12,184 $1.57 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $2,674 - $3,143
22 Added 0.14%
15,759 $2.18 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $486,316 - $536,658
4,073 Added 34.92%
15,737 $1.91 Million
Q1 2018

May 16, 2018

SELL
$125.1 - $148.14 $174,764 - $206,951
-1,397 Reduced 10.7%
11,664 $0
Q4 2017

May 21, 2018

BUY
$131.22 - $143.62 $1.71 Million - $1.88 Million
13,061
13,061 $1.83 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Braun Bostich & Associates Inc. Portfolio

Follow Braun Bostich & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Braun Bostich & Associates Inc. with notifications on news.